NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Relapsed/refractory (r/r) mature B cell neoplasms who have relapsed after one or more prior therapies, including subjects with primary refractory disease
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.